nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—CYP2C19—Ifosfamide—testicular cancer	0.14	0.24	CbGbCtD
Meprobamate—CYP2E1—Etoposide—testicular cancer	0.107	0.183	CbGbCtD
Meprobamate—ABCB1—Dactinomycin—testicular cancer	0.0956	0.164	CbGbCtD
Meprobamate—ABCB1—Vinblastine—testicular cancer	0.0599	0.103	CbGbCtD
Meprobamate—ABCB1—Cisplatin—testicular cancer	0.0549	0.0941	CbGbCtD
Meprobamate—ABCB1—Etoposide—testicular cancer	0.0539	0.0925	CbGbCtD
Meprobamate—ABCB1—Doxorubicin—testicular cancer	0.0368	0.0631	CbGbCtD
Meprobamate—ABCB1—Methotrexate—testicular cancer	0.0356	0.0611	CbGbCtD
Meprobamate—Proctitis—Dactinomycin—testicular cancer	0.0208	0.05	CcSEcCtD
Meprobamate—Slurred speech—Cisplatin—testicular cancer	0.00898	0.0216	CcSEcCtD
Meprobamate—Proctitis—Epirubicin—testicular cancer	0.00845	0.0203	CcSEcCtD
Meprobamate—Proctitis—Doxorubicin—testicular cancer	0.00781	0.0188	CcSEcCtD
Meprobamate—Anuria—Methotrexate—testicular cancer	0.00631	0.0151	CcSEcCtD
Meprobamate—Lymphadenopathy—Chlorambucil—testicular cancer	0.00599	0.0144	CcSEcCtD
Meprobamate—Anuria—Epirubicin—testicular cancer	0.0059	0.0142	CcSEcCtD
Meprobamate—Petechiae—Ifosfamide—testicular cancer	0.00566	0.0136	CcSEcCtD
Meprobamate—Anuria—Doxorubicin—testicular cancer	0.00546	0.0131	CcSEcCtD
Meprobamate—Dysarthria—Ifosfamide—testicular cancer	0.00492	0.0118	CcSEcCtD
Meprobamate—Ataxia—Chlorambucil—testicular cancer	0.00481	0.0115	CcSEcCtD
Meprobamate—Aplastic anaemia—Dactinomycin—testicular cancer	0.00477	0.0115	CcSEcCtD
Meprobamate—Dysarthria—Cisplatin—testicular cancer	0.00425	0.0102	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Chlorambucil—testicular cancer	0.00391	0.00937	CcSEcCtD
Meprobamate—Body temperature increased—Carboplatin—testicular cancer	0.00386	0.00927	CcSEcCtD
Meprobamate—Stomatitis—Chlorambucil—testicular cancer	0.00384	0.00921	CcSEcCtD
Meprobamate—Agranulocytosis—Vinblastine—testicular cancer	0.00337	0.00808	CcSEcCtD
Meprobamate—Bronchospasm—Bleomycin—testicular cancer	0.00336	0.00807	CcSEcCtD
Meprobamate—Rash maculo-papular—Etoposide—testicular cancer	0.00334	0.00802	CcSEcCtD
Meprobamate—Erythema multiforme—Chlorambucil—testicular cancer	0.00334	0.00802	CcSEcCtD
Meprobamate—Stomatitis—Bleomycin—testicular cancer	0.00297	0.00713	CcSEcCtD
Meprobamate—Bronchospasm—Ifosfamide—testicular cancer	0.00287	0.0069	CcSEcCtD
Meprobamate—Agitation—Chlorambucil—testicular cancer	0.00283	0.00679	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Dactinomycin—testicular cancer	0.00282	0.00676	CcSEcCtD
Meprobamate—Angioedema—Chlorambucil—testicular cancer	0.00281	0.00675	CcSEcCtD
Meprobamate—Stomatitis—Dactinomycin—testicular cancer	0.00277	0.00665	CcSEcCtD
Meprobamate—Leukopenia—Chlorambucil—testicular cancer	0.00276	0.00661	CcSEcCtD
Meprobamate—Petechiae—Methotrexate—testicular cancer	0.00268	0.00643	CcSEcCtD
Meprobamate—Agranulocytosis—Dactinomycin—testicular cancer	0.00265	0.00637	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Ifosfamide—testicular cancer	0.00258	0.0062	CcSEcCtD
Meprobamate—Stomatitis—Ifosfamide—testicular cancer	0.00254	0.00609	CcSEcCtD
Meprobamate—Vertigo—Vinblastine—testicular cancer	0.00253	0.00608	CcSEcCtD
Meprobamate—Leukopenia—Vinblastine—testicular cancer	0.00253	0.00606	CcSEcCtD
Meprobamate—Petechiae—Epirubicin—testicular cancer	0.00251	0.00602	CcSEcCtD
Meprobamate—Chills—Bleomycin—testicular cancer	0.00246	0.00589	CcSEcCtD
Meprobamate—Agranulocytosis—Ifosfamide—testicular cancer	0.00243	0.00584	CcSEcCtD
Meprobamate—Erythema multiforme—Dactinomycin—testicular cancer	0.00241	0.00579	CcSEcCtD
Meprobamate—Oliguria—Methotrexate—testicular cancer	0.00239	0.00574	CcSEcCtD
Meprobamate—Dysarthria—Methotrexate—testicular cancer	0.00233	0.00559	CcSEcCtD
Meprobamate—Petechiae—Doxorubicin—testicular cancer	0.00232	0.00557	CcSEcCtD
Meprobamate—Chills—Dactinomycin—testicular cancer	0.00229	0.0055	CcSEcCtD
Meprobamate—Bronchospasm—Etoposide—testicular cancer	0.00227	0.00545	CcSEcCtD
Meprobamate—Oliguria—Epirubicin—testicular cancer	0.00224	0.00537	CcSEcCtD
Meprobamate—Erythema multiforme—Ifosfamide—testicular cancer	0.00221	0.00531	CcSEcCtD
Meprobamate—Stomatitis—Cisplatin—testicular cancer	0.00219	0.00525	CcSEcCtD
Meprobamate—Dysarthria—Epirubicin—testicular cancer	0.00218	0.00523	CcSEcCtD
Meprobamate—Leukopenia—Bleomycin—testicular cancer	0.00213	0.00512	CcSEcCtD
Meprobamate—Chills—Ifosfamide—testicular cancer	0.0021	0.00504	CcSEcCtD
Meprobamate—Arrhythmia—Ifosfamide—testicular cancer	0.00209	0.00501	CcSEcCtD
Meprobamate—Oliguria—Doxorubicin—testicular cancer	0.00207	0.00497	CcSEcCtD
Meprobamate—Aplastic anaemia—Methotrexate—testicular cancer	0.00207	0.00496	CcSEcCtD
Meprobamate—Paraesthesia—Vinblastine—testicular cancer	0.00207	0.00496	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Etoposide—testicular cancer	0.00204	0.0049	CcSEcCtD
Meprobamate—Dysarthria—Doxorubicin—testicular cancer	0.00202	0.00484	CcSEcCtD
Meprobamate—Stomatitis—Etoposide—testicular cancer	0.00201	0.00481	CcSEcCtD
Meprobamate—Ecchymosis—Methotrexate—testicular cancer	0.00199	0.00478	CcSEcCtD
Meprobamate—Leukopenia—Dactinomycin—testicular cancer	0.00199	0.00477	CcSEcCtD
Meprobamate—Body temperature increased—Chlorambucil—testicular cancer	0.00199	0.00477	CcSEcCtD
Meprobamate—Anaphylactic shock—Bleomycin—testicular cancer	0.00194	0.00467	CcSEcCtD
Meprobamate—Aplastic anaemia—Epirubicin—testicular cancer	0.00194	0.00465	CcSEcCtD
Meprobamate—Agranulocytosis—Etoposide—testicular cancer	0.00192	0.00461	CcSEcCtD
Meprobamate—Lymphadenopathy—Methotrexate—testicular cancer	0.00187	0.0045	CcSEcCtD
Meprobamate—Rash maculo-papular—Epirubicin—testicular cancer	0.00187	0.0045	CcSEcCtD
Meprobamate—Agitation—Ifosfamide—testicular cancer	0.00187	0.00449	CcSEcCtD
Meprobamate—Ecchymosis—Epirubicin—testicular cancer	0.00186	0.00447	CcSEcCtD
Meprobamate—Angioedema—Ifosfamide—testicular cancer	0.00186	0.00446	CcSEcCtD
Meprobamate—Hypersensitivity—Chlorambucil—testicular cancer	0.00185	0.00444	CcSEcCtD
Meprobamate—Vertigo—Ifosfamide—testicular cancer	0.00183	0.00439	CcSEcCtD
Meprobamate—Leukopenia—Ifosfamide—testicular cancer	0.00182	0.00437	CcSEcCtD
Meprobamate—Hypotension—Bleomycin—testicular cancer	0.00182	0.00436	CcSEcCtD
Meprobamate—Asthenia—Chlorambucil—testicular cancer	0.0018	0.00433	CcSEcCtD
Meprobamate—Arrhythmia—Cisplatin—testicular cancer	0.0018	0.00432	CcSEcCtD
Meprobamate—Palpitations—Ifosfamide—testicular cancer	0.0018	0.00432	CcSEcCtD
Meprobamate—Aplastic anaemia—Doxorubicin—testicular cancer	0.00179	0.0043	CcSEcCtD
Meprobamate—Pruritus—Chlorambucil—testicular cancer	0.00178	0.00427	CcSEcCtD
Meprobamate—Lymphadenopathy—Epirubicin—testicular cancer	0.00175	0.00421	CcSEcCtD
Meprobamate—Erythema multiforme—Etoposide—testicular cancer	0.00175	0.00419	CcSEcCtD
Meprobamate—Paraesthesia—Bleomycin—testicular cancer	0.00175	0.00419	CcSEcCtD
Meprobamate—Rash maculo-papular—Doxorubicin—testicular cancer	0.00173	0.00416	CcSEcCtD
Meprobamate—Ecchymosis—Doxorubicin—testicular cancer	0.00173	0.00414	CcSEcCtD
Meprobamate—Diarrhoea—Chlorambucil—testicular cancer	0.00172	0.00413	CcSEcCtD
Meprobamate—Hypersensitivity—Vinblastine—testicular cancer	0.0017	0.00407	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Methotrexate—testicular cancer	0.0017	0.00407	CcSEcCtD
Meprobamate—Vascular purpura—Epirubicin—testicular cancer	0.00167	0.00402	CcSEcCtD
Meprobamate—Anaphylactic shock—Ifosfamide—testicular cancer	0.00166	0.00399	CcSEcCtD
Meprobamate—Chills—Etoposide—testicular cancer	0.00166	0.00398	CcSEcCtD
Meprobamate—Asthenia—Vinblastine—testicular cancer	0.00165	0.00396	CcSEcCtD
Meprobamate—Lymphadenopathy—Doxorubicin—testicular cancer	0.00162	0.0039	CcSEcCtD
Meprobamate—Vomiting—Chlorambucil—testicular cancer	0.0016	0.00383	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Epirubicin—testicular cancer	0.00159	0.00381	CcSEcCtD
Meprobamate—Diarrhoea—Vinblastine—testicular cancer	0.00158	0.00378	CcSEcCtD
Meprobamate—Leukopenia—Cisplatin—testicular cancer	0.00157	0.00377	CcSEcCtD
Meprobamate—Dermatitis bullous—Epirubicin—testicular cancer	0.00157	0.00376	CcSEcCtD
Meprobamate—Purpura—Epirubicin—testicular cancer	0.00155	0.00373	CcSEcCtD
Meprobamate—Hypotension—Ifosfamide—testicular cancer	0.00155	0.00373	CcSEcCtD
Meprobamate—Vascular purpura—Doxorubicin—testicular cancer	0.00155	0.00372	CcSEcCtD
Meprobamate—Body temperature increased—Bleomycin—testicular cancer	0.00154	0.00369	CcSEcCtD
Meprobamate—Dizziness—Vinblastine—testicular cancer	0.00152	0.00365	CcSEcCtD
Meprobamate—Ataxia—Methotrexate—testicular cancer	0.0015	0.00361	CcSEcCtD
Meprobamate—Nausea—Chlorambucil—testicular cancer	0.00149	0.00358	CcSEcCtD
Meprobamate—Paraesthesia—Ifosfamide—testicular cancer	0.00149	0.00358	CcSEcCtD
Meprobamate—Somnolence—Ifosfamide—testicular cancer	0.00148	0.00355	CcSEcCtD
Meprobamate—Dermatitis exfoliative—Doxorubicin—testicular cancer	0.00147	0.00352	CcSEcCtD
Meprobamate—Vomiting—Vinblastine—testicular cancer	0.00146	0.00351	CcSEcCtD
Meprobamate—Dermatitis bullous—Doxorubicin—testicular cancer	0.00145	0.00348	CcSEcCtD
Meprobamate—Vertigo—Etoposide—testicular cancer	0.00144	0.00347	CcSEcCtD
Meprobamate—Headache—Vinblastine—testicular cancer	0.00144	0.00346	CcSEcCtD
Meprobamate—Leukopenia—Etoposide—testicular cancer	0.00144	0.00345	CcSEcCtD
Meprobamate—Purpura—Doxorubicin—testicular cancer	0.00144	0.00345	CcSEcCtD
Meprobamate—Body temperature increased—Dactinomycin—testicular cancer	0.00143	0.00344	CcSEcCtD
Meprobamate—Anaphylactic shock—Cisplatin—testicular cancer	0.00143	0.00344	CcSEcCtD
Meprobamate—Hypersensitivity—Bleomycin—testicular cancer	0.00143	0.00344	CcSEcCtD
Meprobamate—Loss of consciousness—Etoposide—testicular cancer	0.00141	0.00339	CcSEcCtD
Meprobamate—Ataxia—Epirubicin—testicular cancer	0.00141	0.00338	CcSEcCtD
Meprobamate—Tachycardia—Cisplatin—testicular cancer	0.0014	0.00336	CcSEcCtD
Meprobamate—Asthenia—Bleomycin—testicular cancer	0.0014	0.00335	CcSEcCtD
Meprobamate—Pruritus—Bleomycin—testicular cancer	0.00138	0.0033	CcSEcCtD
Meprobamate—Eosinophilia—Methotrexate—testicular cancer	0.00137	0.00328	CcSEcCtD
Meprobamate—Nausea—Vinblastine—testicular cancer	0.00137	0.00328	CcSEcCtD
Meprobamate—Hypotension—Cisplatin—testicular cancer	0.00134	0.00321	CcSEcCtD
Meprobamate—Hypersensitivity—Dactinomycin—testicular cancer	0.00134	0.00321	CcSEcCtD
Meprobamate—Body temperature increased—Ifosfamide—testicular cancer	0.00131	0.00315	CcSEcCtD
Meprobamate—Anaphylactic shock—Etoposide—testicular cancer	0.00131	0.00315	CcSEcCtD
Meprobamate—Ataxia—Doxorubicin—testicular cancer	0.0013	0.00313	CcSEcCtD
Meprobamate—Asthenia—Dactinomycin—testicular cancer	0.0013	0.00312	CcSEcCtD
Meprobamate—Paraesthesia—Cisplatin—testicular cancer	0.00129	0.00309	CcSEcCtD
Meprobamate—Tachycardia—Etoposide—testicular cancer	0.00128	0.00307	CcSEcCtD
Meprobamate—Eosinophilia—Epirubicin—testicular cancer	0.00128	0.00307	CcSEcCtD
Meprobamate—Diarrhoea—Dactinomycin—testicular cancer	0.00124	0.00298	CcSEcCtD
Meprobamate—Vomiting—Bleomycin—testicular cancer	0.00124	0.00297	CcSEcCtD
Meprobamate—Drowsiness—Methotrexate—testicular cancer	0.00123	0.00296	CcSEcCtD
Meprobamate—Hypotension—Etoposide—testicular cancer	0.00123	0.00294	CcSEcCtD
Meprobamate—Dermatitis—Bleomycin—testicular cancer	0.00122	0.00294	CcSEcCtD
Meprobamate—Hypersensitivity—Ifosfamide—testicular cancer	0.00122	0.00294	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.00122	0.00293	CcSEcCtD
Meprobamate—Stomatitis—Methotrexate—testicular cancer	0.0012	0.00288	CcSEcCtD
Meprobamate—Asthenia—Ifosfamide—testicular cancer	0.00119	0.00286	CcSEcCtD
Meprobamate—Eosinophilia—Doxorubicin—testicular cancer	0.00119	0.00284	CcSEcCtD
Meprobamate—Paraesthesia—Etoposide—testicular cancer	0.00118	0.00283	CcSEcCtD
Meprobamate—Pruritus—Ifosfamide—testicular cancer	0.00118	0.00282	CcSEcCtD
Meprobamate—Somnolence—Etoposide—testicular cancer	0.00117	0.0028	CcSEcCtD
Meprobamate—Nausea—Bleomycin—testicular cancer	0.00116	0.00277	CcSEcCtD
Meprobamate—Drowsiness—Epirubicin—testicular cancer	0.00115	0.00277	CcSEcCtD
Meprobamate—Vomiting—Dactinomycin—testicular cancer	0.00115	0.00277	CcSEcCtD
Meprobamate—Agranulocytosis—Methotrexate—testicular cancer	0.00115	0.00276	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.00114	0.00274	CcSEcCtD
Meprobamate—Diarrhoea—Ifosfamide—testicular cancer	0.00114	0.00273	CcSEcCtD
Meprobamate—Body temperature increased—Cisplatin—testicular cancer	0.00113	0.00272	CcSEcCtD
Meprobamate—Stomatitis—Epirubicin—testicular cancer	0.00112	0.0027	CcSEcCtD
Meprobamate—Dizziness—Ifosfamide—testicular cancer	0.0011	0.00264	CcSEcCtD
Meprobamate—Nausea—Dactinomycin—testicular cancer	0.00108	0.00258	CcSEcCtD
Meprobamate—Agranulocytosis—Epirubicin—testicular cancer	0.00108	0.00258	CcSEcCtD
Meprobamate—Drowsiness—Doxorubicin—testicular cancer	0.00107	0.00256	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	0.00106	0.00254	CcSEcCtD
Meprobamate—Vomiting—Ifosfamide—testicular cancer	0.00106	0.00254	CcSEcCtD
Meprobamate—Hypersensitivity—Cisplatin—testicular cancer	0.00106	0.00253	CcSEcCtD
Meprobamate—Dermatitis—Ifosfamide—testicular cancer	0.00105	0.00251	CcSEcCtD
Meprobamate—Erythema multiforme—Methotrexate—testicular cancer	0.00105	0.00251	CcSEcCtD
Meprobamate—Stomatitis—Doxorubicin—testicular cancer	0.00104	0.0025	CcSEcCtD
Meprobamate—Body temperature increased—Etoposide—testicular cancer	0.00104	0.00249	CcSEcCtD
Meprobamate—Asthenia—Cisplatin—testicular cancer	0.00103	0.00247	CcSEcCtD
Meprobamate—Oedema peripheral—Epirubicin—testicular cancer	0.00102	0.00245	CcSEcCtD
Meprobamate—Agranulocytosis—Doxorubicin—testicular cancer	0.000996	0.00239	CcSEcCtD
Meprobamate—Chills—Methotrexate—testicular cancer	0.000993	0.00238	CcSEcCtD
Meprobamate—Nausea—Ifosfamide—testicular cancer	0.000987	0.00237	CcSEcCtD
Meprobamate—Diarrhoea—Cisplatin—testicular cancer	0.00098	0.00235	CcSEcCtD
Meprobamate—Erythema multiforme—Epirubicin—testicular cancer	0.000979	0.00235	CcSEcCtD
Meprobamate—Hypersensitivity—Etoposide—testicular cancer	0.000967	0.00232	CcSEcCtD
Meprobamate—Oedema peripheral—Doxorubicin—testicular cancer	0.000944	0.00227	CcSEcCtD
Meprobamate—Asthenia—Etoposide—testicular cancer	0.000942	0.00226	CcSEcCtD
Meprobamate—Chills—Epirubicin—testicular cancer	0.000929	0.00223	CcSEcCtD
Meprobamate—Pruritus—Etoposide—testicular cancer	0.000929	0.00223	CcSEcCtD
Meprobamate—Arrhythmia—Epirubicin—testicular cancer	0.000925	0.00222	CcSEcCtD
Meprobamate—Vomiting—Cisplatin—testicular cancer	0.000911	0.00219	CcSEcCtD
Meprobamate—Erythema multiforme—Doxorubicin—testicular cancer	0.000906	0.00217	CcSEcCtD
Meprobamate—Dermatitis—Cisplatin—testicular cancer	0.000903	0.00217	CcSEcCtD
Meprobamate—Diarrhoea—Etoposide—testicular cancer	0.000898	0.00216	CcSEcCtD
Meprobamate—Dizziness—Etoposide—testicular cancer	0.000868	0.00208	CcSEcCtD
Meprobamate—Vertigo—Methotrexate—testicular cancer	0.000865	0.00208	CcSEcCtD
Meprobamate—Leukopenia—Methotrexate—testicular cancer	0.000862	0.00207	CcSEcCtD
Meprobamate—Chills—Doxorubicin—testicular cancer	0.00086	0.00206	CcSEcCtD
Meprobamate—Arrhythmia—Doxorubicin—testicular cancer	0.000856	0.00205	CcSEcCtD
Meprobamate—Nausea—Cisplatin—testicular cancer	0.000851	0.00204	CcSEcCtD
Meprobamate—Vomiting—Etoposide—testicular cancer	0.000835	0.002	CcSEcCtD
Meprobamate—Agitation—Epirubicin—testicular cancer	0.000828	0.00199	CcSEcCtD
Meprobamate—Dermatitis—Etoposide—testicular cancer	0.000827	0.00198	CcSEcCtD
Meprobamate—Headache—Etoposide—testicular cancer	0.000822	0.00197	CcSEcCtD
Meprobamate—Vertigo—Epirubicin—testicular cancer	0.00081	0.00194	CcSEcCtD
Meprobamate—Syncope—Epirubicin—testicular cancer	0.000808	0.00194	CcSEcCtD
Meprobamate—Leukopenia—Epirubicin—testicular cancer	0.000807	0.00194	CcSEcCtD
Meprobamate—Palpitations—Epirubicin—testicular cancer	0.000797	0.00191	CcSEcCtD
Meprobamate—Loss of consciousness—Epirubicin—testicular cancer	0.000792	0.0019	CcSEcCtD
Meprobamate—Anaphylactic shock—Methotrexate—testicular cancer	0.000786	0.00189	CcSEcCtD
Meprobamate—Nausea—Etoposide—testicular cancer	0.00078	0.00187	CcSEcCtD
Meprobamate—Agitation—Doxorubicin—testicular cancer	0.000767	0.00184	CcSEcCtD
Meprobamate—Vertigo—Doxorubicin—testicular cancer	0.000749	0.0018	CcSEcCtD
Meprobamate—Syncope—Doxorubicin—testicular cancer	0.000748	0.0018	CcSEcCtD
Meprobamate—Leukopenia—Doxorubicin—testicular cancer	0.000747	0.00179	CcSEcCtD
Meprobamate—Palpitations—Doxorubicin—testicular cancer	0.000737	0.00177	CcSEcCtD
Meprobamate—Anaphylactic shock—Epirubicin—testicular cancer	0.000736	0.00177	CcSEcCtD
Meprobamate—Hypotension—Methotrexate—testicular cancer	0.000735	0.00176	CcSEcCtD
Meprobamate—Loss of consciousness—Doxorubicin—testicular cancer	0.000733	0.00176	CcSEcCtD
Meprobamate—Shock—Epirubicin—testicular cancer	0.000724	0.00174	CcSEcCtD
Meprobamate—Tachycardia—Epirubicin—testicular cancer	0.000718	0.00172	CcSEcCtD
Meprobamate—Paraesthesia—Methotrexate—testicular cancer	0.000706	0.00169	CcSEcCtD
Meprobamate—Somnolence—Methotrexate—testicular cancer	0.000699	0.00168	CcSEcCtD
Meprobamate—Hypotension—Epirubicin—testicular cancer	0.000687	0.00165	CcSEcCtD
Meprobamate—Anaphylactic shock—Doxorubicin—testicular cancer	0.000681	0.00163	CcSEcCtD
Meprobamate—Shock—Doxorubicin—testicular cancer	0.00067	0.00161	CcSEcCtD
Meprobamate—Tachycardia—Doxorubicin—testicular cancer	0.000664	0.00159	CcSEcCtD
Meprobamate—Paraesthesia—Epirubicin—testicular cancer	0.000661	0.00159	CcSEcCtD
Meprobamate—Somnolence—Epirubicin—testicular cancer	0.000654	0.00157	CcSEcCtD
Meprobamate—Hypotension—Doxorubicin—testicular cancer	0.000636	0.00153	CcSEcCtD
Meprobamate—Body temperature increased—Methotrexate—testicular cancer	0.000621	0.00149	CcSEcCtD
Meprobamate—Paraesthesia—Doxorubicin—testicular cancer	0.000611	0.00147	CcSEcCtD
Meprobamate—Somnolence—Doxorubicin—testicular cancer	0.000605	0.00145	CcSEcCtD
Meprobamate—Body temperature increased—Epirubicin—testicular cancer	0.000582	0.0014	CcSEcCtD
Meprobamate—Hypersensitivity—Methotrexate—testicular cancer	0.000579	0.00139	CcSEcCtD
Meprobamate—Asthenia—Methotrexate—testicular cancer	0.000564	0.00135	CcSEcCtD
Meprobamate—Pruritus—Methotrexate—testicular cancer	0.000556	0.00133	CcSEcCtD
Meprobamate—Hypersensitivity—Epirubicin—testicular cancer	0.000542	0.0013	CcSEcCtD
Meprobamate—Body temperature increased—Doxorubicin—testicular cancer	0.000538	0.00129	CcSEcCtD
Meprobamate—Diarrhoea—Methotrexate—testicular cancer	0.000538	0.00129	CcSEcCtD
Meprobamate—Asthenia—Epirubicin—testicular cancer	0.000528	0.00127	CcSEcCtD
Meprobamate—Pruritus—Epirubicin—testicular cancer	0.000521	0.00125	CcSEcCtD
Meprobamate—Dizziness—Methotrexate—testicular cancer	0.00052	0.00125	CcSEcCtD
Meprobamate—Diarrhoea—Epirubicin—testicular cancer	0.000503	0.00121	CcSEcCtD
Meprobamate—Hypersensitivity—Doxorubicin—testicular cancer	0.000502	0.0012	CcSEcCtD
Meprobamate—Vomiting—Methotrexate—testicular cancer	0.0005	0.0012	CcSEcCtD
Meprobamate—Dermatitis—Methotrexate—testicular cancer	0.000495	0.00119	CcSEcCtD
Meprobamate—Headache—Methotrexate—testicular cancer	0.000493	0.00118	CcSEcCtD
Meprobamate—Asthenia—Doxorubicin—testicular cancer	0.000488	0.00117	CcSEcCtD
Meprobamate—Dizziness—Epirubicin—testicular cancer	0.000487	0.00117	CcSEcCtD
Meprobamate—Pruritus—Doxorubicin—testicular cancer	0.000482	0.00116	CcSEcCtD
Meprobamate—Vomiting—Epirubicin—testicular cancer	0.000468	0.00112	CcSEcCtD
Meprobamate—Nausea—Methotrexate—testicular cancer	0.000467	0.00112	CcSEcCtD
Meprobamate—Diarrhoea—Doxorubicin—testicular cancer	0.000466	0.00112	CcSEcCtD
Meprobamate—Dermatitis—Epirubicin—testicular cancer	0.000463	0.00111	CcSEcCtD
Meprobamate—Headache—Epirubicin—testicular cancer	0.000461	0.00111	CcSEcCtD
Meprobamate—Dizziness—Doxorubicin—testicular cancer	0.00045	0.00108	CcSEcCtD
Meprobamate—Nausea—Epirubicin—testicular cancer	0.000437	0.00105	CcSEcCtD
Meprobamate—Vomiting—Doxorubicin—testicular cancer	0.000433	0.00104	CcSEcCtD
Meprobamate—Dermatitis—Doxorubicin—testicular cancer	0.000429	0.00103	CcSEcCtD
Meprobamate—Headache—Doxorubicin—testicular cancer	0.000426	0.00102	CcSEcCtD
Meprobamate—Nausea—Doxorubicin—testicular cancer	0.000404	0.00097	CcSEcCtD
